Davita Company Profile (NYSE:DVA)

About Davita (NYSE:DVA)

Davita logoDaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. Its DMG division is a patient- and physician-focused integrated healthcare delivery and management company that provides medical services to members through capitation contracts. Its segments include U.S. dialysis and related lab services, DMG, and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2016, it had operated or provided administrative services to 154 outpatient dialysis centers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Specialized Health Services
  • Sub-Industry: Health Care Services
  • Symbol: NYSE:DVA
  • CUSIP: 23918K10
  • Web: www.davita.com
  • Market Cap: $12.6 billion
  • Outstanding Shares: 194,600,000
Average Prices:
  • 50 Day Moving Avg: $66.78
  • 200 Day Moving Avg: $65.57
  • 52 Week Range: $54.50 - $78.77
  • Trailing P/E Ratio: 10.63
  • Foreward P/E Ratio: 16.60
  • P/E Growth: 1.38
Sales & Book Value:
  • Annual Revenue: $14.85 billion
  • Price / Sales: 0.85
  • Book Value: $26.41 per share
  • Price / Book: 2.45
  • EBIDTA: $2.46 billion
  • Net Margins: 4.92%
  • Return on Equity: 16.16%
  • Return on Assets: 4.35%
  • Debt-to-Equity Ratio: 1.75%
  • Current Ratio: 1.61%
  • Quick Ratio: 1.54%
  • Average Volume: 1.27 million shs.
  • Beta: 1.02
  • Short Ratio: 0.15

Frequently Asked Questions for Davita (NYSE:DVA)

What is Davita's stock symbol?

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

How were Davita's earnings last quarter?

Davita Inc (NYSE:DVA) posted its earnings results on Tuesday, May, 2nd. The company reported $0.79 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.82 by $0.02. The business had revenue of $3.70 billion for the quarter, compared to analyst estimates of $3.69 billion. Davita had a return on equity of 16.16% and a net margin of 4.92%. View Davita's Earnings History.

Where is Davita's stock going? Where will Davita's stock price be in 2017?

10 equities research analysts have issued 12 month price objectives for Davita's shares. Their forecasts range from $62.00 to $75.00. On average, they expect Davita's share price to reach $68.67 in the next year. View Analyst Ratings for Davita.

Who are some of Davita's key competitors?

Who owns Davita stock?

Davita's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (7.75%), BlackRock Inc. (6.63%), State Street Corp (3.87%), Boston Partners (3.50%), Bank of New York Mellon Corp (1.61%) and Principal Financial Group Inc. (1.47%). Company insiders that own Davita stock include Carol Anthony Davidson, Charles Berg, Dennis Kogod, James K Hilger, Javier Rodriguez, Jeanine Marie Jiganti, John M Nehra, Kent J Thiry, Kim M Rivera, Laura Mildenberger, Leanne M Zumwalt, Michael David Staffieri, Pamela M Arway, Robert J Margolis, Roger Valine and William L Roper. View Institutional Ownership Trends for Davita.

Who sold Davita stock? Who is selling Davita stock?

Davita's stock was sold by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Morgan Stanley, Nordea Investment Management AB, Holland Capital Management LLC, FMR LLC, Manning & Napier Advisors LLC, Becker Capital Management Inc. and Gotham Asset Management LLC. Company insiders that have sold Davita stock in the last year include Charles Berg, Javier Rodriguez, Jeanine Marie Jiganti, Michael David Staffieri and William L Roper. View Insider Buying and Selling for Davita.

Who bought Davita stock? Who is buying Davita stock?

Davita's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Park West Asset Management LLC, Tudor Investment Corp ET AL, First Trust Advisors LP, FIL Ltd, Highbridge Capital Management LLC, Renaissance Technologies LLC and Vanguard Group Inc.. View Insider Buying and Selling for Davita.

How do I buy Davita stock?

Shares of Davita can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Davita stock cost?

One share of Davita stock can currently be purchased for approximately $64.75.

MarketBeat Community Rating for Davita (NYSE:DVA)
Community Ranking:  2.5 out of 5 (  )
Outperform Votes:  225 (Vote Outperform)
Underperform Votes:  222 (Vote Underperform)
Total Votes:  447
These ratings are a survey of what our community members think about Davita. An outperform vote indicates that you believe the stock will outperform the S&P 500 over the long term. An underperform vote indicates that you believe the stock will underperform the S&P 500.

Analyst Ratings

Consensus Ratings for Davita (NYSE:DVA) (?)
Ratings Breakdown: 1 Sell Rating, 6 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $68.67 (6.05% upside)

Analysts' Ratings History for Davita (NYSE:DVA)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/26/2017Jefferies Group LLCSet Price TargetBuy$70.00N/AView Rating Details
5/25/2017Goldman Sachs Group IncReiterated RatingSell$62.00HighView Rating Details
2/17/2017Royal Bank of CanadaReiterated RatingHold$62.00N/AView Rating Details
12/13/2016Robert W. BairdDowngradeOutperform -> Neutral$68.00 -> $69.00N/AView Rating Details
11/21/2016Bank of America CorpReiterated RatingHold$68.00N/AView Rating Details
11/1/2016Wells Fargo & CoReiterated RatingOutperformN/AView Rating Details
10/13/2016SunTrust Banks, Inc.Set Price TargetHold$66.00N/AView Rating Details
9/20/2016Raymond James Financial, Inc.UpgradeMarket Perform -> Outperform$75.00N/AView Rating Details
9/6/2016Citigroup IncInitiated CoverageNeutral$71.00N/AView Rating Details
8/9/2016JPMorgan Chase & Co.Boost Price TargetNeutral$74.00 -> $75.00N/AView Rating Details
4/6/2016Susquehanna Bancshares IncBoost Price TargetNeutral$70.00 -> $78.00N/AView Rating Details
3/2/2016Sanford C. BernsteinLower Price TargetMarket Perform$74.50 -> $71.00N/AView Rating Details
2/12/2016William BlairReiterated RatingBuyN/AView Rating Details
2/12/2016Piper Jaffray CompaniesReiterated RatingOverweight$90.00 -> $85.00N/AView Rating Details
(Data available from 5/28/2015 forward)


Earnings History for Davita (NYSE:DVA)
Earnings by Quarter for Davita (NYSE:DVA)
Earnings History by Quarter for Davita (NYSE:DVA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2017Q1 2017$0.82$0.79$3.69 billion$3.70 billionViewListenView Earnings Details
2/16/2017Q4 2016$0.91$0.98$3.74 billion$3.72 billionViewListenView Earnings Details
11/2/2016Q316$0.94$0.95$3.72 billion$3.73 billionViewListenView Earnings Details
8/8/2016Q216$0.98$1.01$3.67 billion$3.72 billionViewListenView Earnings Details
5/4/2016Q116$0.86$0.92$3.51 billion$3.58 billionViewListenView Earnings Details
2/11/2016Q415$0.97$1.01$3.50 billion$3.53 billionViewListenView Earnings Details
11/3/2015Q315$0.97$1.00$3.46 billion$3.53 billionViewListenView Earnings Details
8/4/2015Q215$0.95$0.95$3.37 billion$3.43 billionViewListenView Earnings Details
5/4/2015Q115$0.86$0.86$3.25 billion$3.29 billionViewListenView Earnings Details
2/12/2015Q414$0.89$0.96$3.26 billion$3.33 billionViewListenView Earnings Details
11/6/2014Q314$0.91$0.90$3.19 billion$3.25 billionViewListenView Earnings Details
7/31/2014Q214$0.88$0.95$3.10 billion$3.17 billionViewListenView Earnings Details
5/1/2014Q1$0.87$0.85$3.02 billion$3.04 billionViewListenView Earnings Details
2/11/2014Q413$1.91$0.99$2.92 billion$3.06 billionViewListenView Earnings Details
11/5/2013Q313$0.96$0.98$2.93 billion$3.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$1.84$1.84$2.88 billion$2.87 billionViewListenView Earnings Details
5/7/2013Q1 2013$1.80$1.84$2.78 billion$2.83 billionViewListenView Earnings Details
2/14/2013Q4 2012$1.60$1.85$2.40 billion$2.48 billionViewListenView Earnings Details
10/30/2012$1.55$1.56ViewN/AView Earnings Details
8/1/2012$1.47$1.49ViewN/AView Earnings Details
2/16/2012$1.49$1.58ViewN/AView Earnings Details
11/3/2011$1.46$1.45ViewN/AView Earnings Details
8/3/2011$1.14$1.17ViewN/AView Earnings Details
5/2/2011$0.95$0.96ViewN/AView Earnings Details
2/10/2011$1.12$0.70ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Davita (NYSE:DVA)
2017 EPS Consensus Estimate: $3.53
2018 EPS Consensus Estimate: $3.85
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.77$0.84$0.81
Q2 20173$0.90$0.92$0.91
Q3 20173$0.89$0.97$0.93
Q4 20173$0.80$0.92$0.88
Q1 20182$0.87$0.88$0.88
Q2 20182$0.99$1.02$1.01
Q3 20182$1.01$1.02$1.02
Q4 20182$0.89$1.01$0.95
(Data provided by Zacks Investment Research)


Dividend History for Davita (NYSE:DVA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Davita (NYSE:DVA)
Insider Ownership Percentage: 2.10%
Institutional Ownership Percentage: 85.31%
Insider Trades by Quarter for Davita (NYSE:DVA)
Institutional Ownership by Quarter for Davita (NYSE:DVA)
Insider Trades by Quarter for Davita (NYSE:DVA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/15/2017Javier RodriguezCEOSell1,294$66.21$85,675.74View SEC Filing  
5/9/2017Charles BergDirectorSell8,414$65.80$553,641.20View SEC Filing  
5/4/2017William L RoperDirectorSell12,994$65.89$856,174.66View SEC Filing  
8/9/2016Michael David StaffieriCOOSell20,262$73.09$1,480,949.58View SEC Filing  
7/11/2016Jeanine Marie JigantiInsiderSell1,291$78.51$101,356.41View SEC Filing  
7/1/2016Jeanine Marie JigantiInsiderSell4,620$77.45$357,819.00View SEC Filing  
5/25/2016Pamela M ArwayDirectorSell10,824$77.16$835,179.84View SEC Filing  
5/23/2016James K HilgerCFOSell3,416$76.79$262,314.64View SEC Filing  
5/20/2016Kent J ThiryCEOSell32,880$76.99$2,531,431.20View SEC Filing  
5/17/2016Dennis KogodCEOSell17,700$77.35$1,369,095.00View SEC Filing  
5/17/2016Leanne M ZumwaltVPSell538$77.08$41,469.04View SEC Filing  
5/16/2016James K HilgerCFOSell3,983$75.59$301,074.97View SEC Filing  
5/16/2016Javier RodriguezCEOSell36,466$75.44$2,750,995.04View SEC Filing  
5/16/2016Michael David StaffieriCOOSell4,934$75.69$373,454.46View SEC Filing  
5/12/2016Roger ValineDirectorSell8,220$76.34$627,514.80View SEC Filing  
5/10/2016Dennis KogodCEOSell40,048$76.25$3,053,660.00View SEC Filing  
5/6/2016John M NehraDirectorSell16,314$75.56$1,232,685.84View SEC Filing  
4/11/2016Javier RodriguezCEOSell89,912$73.51$6,609,431.12View SEC Filing  
3/21/2016Dennis KogodCEOSell13,455$72.12$970,374.60View SEC Filing  
2/29/2016Pamela M ArwayDirectorSell9,026$66.00$595,716.00View SEC Filing  
2/23/2016Leanne M. ZumwaltVPSell14,587$64.25$937,214.75View SEC Filing  
2/16/2016Dennis KogodCEOSell33,290$61.99$2,063,647.10View SEC Filing  
12/17/2015Laura MildenbergerinsiderSell1,440$68.14$98,121.60View SEC Filing  
9/22/2015Kim M. RiverainsiderSell40,037$75.48$3,021,992.76View SEC Filing  
8/17/2015Carol Anthony DavidsonDirectorSell4,038$79.93$322,757.34View SEC Filing  
6/4/2015Robert J MargolisChairmanSell31,400$83.39$2,618,446.00View SEC Filing  
5/28/2015Michael David StaffieriCOOSell9,050$84.07$760,833.50View SEC Filing  
5/19/2015Robert J MargolisChairmanSell15,700$83.22$1,306,554.00View SEC Filing  
5/18/2015James K HilgerCFOSell3,983$82.10$327,004.30View SEC Filing  
5/18/2015Michael David StaffieriCOOSell2,047$82.03$167,915.41View SEC Filing  
5/18/2015Robert J MargolisChairmanSell15,700$82.24$1,291,168.00View SEC Filing  
5/11/2015James K HilgerCFOSell8,267$82.00$677,894.00View SEC Filing  
5/11/2015Jeanine Marie JigantiInsiderSell2,481$81.95$203,317.95View SEC Filing  
5/11/2015John M NehraDirectorSell12,278$81.85$1,004,954.30View SEC Filing  
4/21/2015Robert J MargolisChairmanSell31,400$82.40$2,587,360.00View SEC Filing  
4/7/2015Robert J MargolisChairmanSell15,700$82.15$1,289,755.00View SEC Filing  
4/6/2015Robert J MargolisChairmanSell15,700$81.49$1,279,393.00View SEC Filing  
3/27/2015Robert J MargolisChairmanSell31,400$81.18$2,549,052.00View SEC Filing  
3/12/2015Robert J MargolisChairmanSell107,374$79.24$8,508,315.76View SEC Filing  
2/27/2015Robert J MargolisChairmanSell21,000$74.29$1,560,090.00View SEC Filing  
2/19/2015Robert J MargolisChairmanSell21,000$73.12$1,535,520.00View SEC Filing  
1/30/2015Robert J MargolisChairmanSell31,400$75.48$2,370,072.00View SEC Filing  
1/23/2015Michael David StaffieriCOOSell21,869$76.05$1,663,137.45View SEC Filing  
1/16/2015Robert J MargolisChairmanSell31,400$74.92$2,352,488.00View SEC Filing  
1/8/2015Kim M RiveraInsiderSell1,111$75.10$83,436.10View SEC Filing  
12/30/2014Robert J MargolisChairmanSell31,400$76.09$2,389,226.00View SEC Filing  
12/29/2014Robert J MargolisChairmanSell15,700$76.09$1,194,613.00View SEC Filing  
12/19/2014Laura MildenbergerInsiderSell1,446$75.50$109,173.00View SEC Filing  
12/18/2014Robert J MargolisChairmanSell31,400$74.67$2,344,638.00View SEC Filing  
12/3/2014Robert J MargolisChairmanSell31,400$75.80$2,380,120.00View SEC Filing  
12/1/2014Kim M RiveraInsiderSell6,503$76.08$494,748.24View SEC Filing  
11/21/2014Robert J MargolisChairmanSell31,400$75.08$2,357,512.00View SEC Filing  
11/11/2014Kent J ThiryCEOSell344,938$74.52$25,704,779.76View SEC Filing  
11/11/2014Robert J MargolisChairmanSell250,000$75.09$18,772,500.00View SEC Filing  
11/10/2014Berkshire Hathaway IncMajor ShareholderBuy944,418$74.11$69,990,817.98View SEC Filing  
11/7/2014R. Ted WeschlerMajor ShareholderBuy820,018$74.10$60,763,333.80View SEC Filing  
11/3/2014Roger ValineDirectorSell7,185$77.85$559,352.25View SEC Filing  
9/16/2014John M NehraDirectorSell20,000$73.91$1,478,200.00View SEC Filing  
9/8/2014Kim M RiveraInsiderSell1,111$74.25$82,491.75View SEC Filing  
8/27/2014Leanne M ZumwaltVPSell3,214$74.57$239,667.98View SEC Filing  
8/11/2014Jeanine Marie JigantiInsiderSell2,500$72.14$180,350.00View SEC Filing  
6/11/2014Kim M RiveraInsiderSell5,929$71.05$421,255.45View SEC Filing  
5/29/2014Laura MildenbergerInsiderSell5,080$69.99$355,549.20View SEC Filing  
5/16/2014Dennis KogodCOOSell18,750$67.30$1,261,875.00View SEC Filing  
5/16/2014Kent ThiryCEOSell17,600$67.41$1,186,416.00View SEC Filing  
5/15/2014James HilgerCAOSell1,666$67.23$112,005.18View SEC Filing  
5/15/2014Javier RodriguezCEOSell7,000$67.50$472,500.00View SEC Filing  
5/12/2014Dennis KogodCOOSell32,188$68.06$2,190,715.28View SEC Filing  
5/8/2014Dennis KogodCOOSell32,213$67.36$2,169,867.68View SEC Filing  
5/7/2014Michael David StaffieriCOOSell2,633$67.30$177,200.90View SEC Filing  
4/2/2014Michael David StaffieriCOOSell2,867$69.15$198,253.05View SEC Filing  
3/20/2014Laura MildenbergerInsiderSell3,274$70.04$229,310.96View SEC Filing  
2/26/2014R. Ted Weschlermajor shareholderBuy1,159,858$66.97$77,675,690.26View SEC Filing  
2/21/2014John NehraDirectorSell40,000$65.81$2,632,400.00View SEC Filing  
2/18/2014William RoperDirectorSell42,519$66.37$2,821,986.03View SEC Filing  
12/20/2013Laura MildenbergerInsiderSell10,417$62.53$651,375.01View SEC Filing  
12/17/2013Allen NissensonInsiderSell2,929$59.83$175,242.07View SEC Filing  
12/9/2013Berkshire Hathaway Incmajor shareholderBuy1,314,170$57.84$76,011,592.80View SEC Filing  
11/8/2013R. Ted Weschlermajor shareholderBuy3,700,294$55.14$204,034,211.16View SEC Filing  
7/5/2013Berkshire Hathaway IncMajor ShareholderBuy110,309$114.01$12,576,329.09View SEC Filing  
7/3/2013R. Ted WeschlerMajor ShareholderBuy639,200$114.78$73,367,376.00View SEC Filing  
5/15/2013David T ShapiroInsiderSell8,779$129.80$1,139,514.20View SEC Filing  
5/15/2013Dennis KogodCOOSell21,130$129.47$2,735,701.10View SEC Filing  
5/15/2013James K HilgerCFOSell1,049$130.18$136,558.82View SEC Filing  
5/15/2013Leanne M ZumwaltVPSell13,209$129.59$1,711,754.31View SEC Filing  
5/13/2013Kent J ThiryCEOSell243,307$129.95$31,617,744.65View SEC Filing  
5/13/2013Kim M RiveraInsiderSell1,672$129.70$216,858.40View SEC Filing  
3/4/2013Berkshire Hathaway IncMajor ShareholderBuy164,947$119.59$19,726,011.73View SEC Filing  
3/4/2013Roger ValineDirectorSell1,390$120.00$166,800.00View SEC Filing  
2/27/2013Berkshire Hathaway IncMajor ShareholderBuy211,889$116.56$24,697,781.84View SEC Filing  
2/22/2013Berkshire Hathaway IncMajor ShareholderBuy224,091$115.88$25,967,665.08View SEC Filing  
2/19/2013Berkshire Hathaway IncMajor ShareholderBuy323,070$116.73$37,711,961.10View SEC Filing  
2/5/2013Berkshire Hathaway IncMajor ShareholderBuy32,376$115.17$3,728,743.92View SEC Filing  
2/4/2013Roger ValineDirectorSell1,389$116.13$161,304.57View SEC Filing  
1/16/2013Berkshire Hathaway IncMajor ShareholderBuy42,400$111.33$4,720,392.00View SEC Filing  
1/15/2013Berkshire Hathaway IncMajor ShareholderBuy179,300$109.67$19,663,831.00View SEC Filing  
1/10/2013Berkshire Hathaway IncMajor ShareholderBuy187,898$109.54$20,582,346.92View SEC Filing  
12/24/2012Dennis KogodCOOSell12,736$111.00$1,413,696.00View SEC Filing  
12/21/2012James K HilgerCFOSell2,073$112.20$232,590.60View SEC Filing  
12/6/2012Berkshire Hathaway IncMajor ShareholderBuy635,633$106.20$67,504,224.60View SEC Filing  
11/29/2012Berkshire Hathaway IncMajor ShareholderBuy679,249$108.20$73,494,741.80View SEC Filing  
11/26/2012Berkshire Hathaway IncMajor ShareholderBuy412,050$110.38$45,482,079.00View SEC Filing  
11/16/2012Berkshire Hathaway IncMajor ShareholderBuy132,958$112.45$14,951,127.10View SEC Filing  
11/12/2012Berkshire Hathaway IncMajor ShareholderBuy548,823$112.15$61,550,499.45View SEC Filing  
11/7/2012Berkshire Hathaway IncMajor ShareholderBuy139,491$112.03$15,627,176.73View SEC Filing  
11/2/2012Berkshire Hathaway IncMajor ShareholderBuy254,750$112.20$28,582,950.00View SEC Filing  
10/26/2012Berkshire Hathaway IncMajor ShareholderBuy257,941$111.14$28,667,562.74View SEC Filing  
10/17/2012Berkshire Hathaway IncMajor ShareholderBuy63,928$109.56$7,003,951.68View SEC Filing  
10/12/2012Berkshire Hathaway IncMajor ShareholderBuy217,597$109.76$23,883,446.72View SEC Filing  
10/9/2012Berkshire Hathaway IncMajor ShareholderBuy67,946$107.71$7,318,463.66View SEC Filing  
9/28/2012Berkshire Hathaway IncMajor ShareholderBuy282,403$102.03$28,813,578.09View SEC Filing  
8/8/2012Kent J ThiryChairmanSell320,877$96.88$31,086,563.76View SEC Filing  
8/7/2012William L RoperDirectorSell23,019$95.95$2,208,673.05View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Davita (NYSE:DVA)
Latest Headlines for Davita (NYSE:DVA)
americanbankingnews.com logo Brokerages Anticipate Davita Inc (DVA) Will Announce Quarterly Sales of $3.83 Billion
www.americanbankingnews.com - May 28 at 9:08 AM
americanbankingnews.com logoJefferies Group LLC Analysts Give Davita Inc (DVA) a $70.00 Price Target
www.americanbankingnews.com - May 27 at 8:24 AM
nasdaq.com logoCommit To Purchase DaVita At $57.50, Earn 5.1% Annualized Using Options
www.nasdaq.com - May 26 at 5:25 PM
americanbankingnews.com logoZacks: Analysts Anticipate Davita Inc (DVA) to Announce $0.90 EPS
www.americanbankingnews.com - May 26 at 12:50 PM
finance.yahoo.com logoDaVita Celebrates Military Appreciation Month
finance.yahoo.com - May 26 at 4:45 AM
nasdaq.com logoDaVita (DVA) Shares Cross Above 200 DMA - Nasdaq
www.nasdaq.com - May 25 at 11:44 PM
prnewswire.com logoDaVita adquiere Centrum Dializa II - PR Newswire - PR Newswire (Comunicado de prensa)
www.prnewswire.com - May 25 at 6:43 PM
finance.yahoo.com logoDaVita acquires Polish dialysis company
finance.yahoo.com - May 25 at 6:43 PM
americanbankingnews.com logoDavita Inc (DVA) Given Sell Rating at Goldman Sachs Group Inc
www.americanbankingnews.com - May 25 at 6:11 PM
finance.yahoo.com logoDaVita Kidney Care Welcomes Eric Severson as Chief People Officer
finance.yahoo.com - May 24 at 12:29 PM
prnewswire.com logoDaVita Honors Commitment to Healthy Living during Employee Health and Fitness ...
www.prnewswire.com - May 23 at 12:23 PM
finance.yahoo.com logoDaVita Honors Commitment to Healthy Living during Employee Health and Fitness Month
finance.yahoo.com - May 23 at 12:23 PM
finance.yahoo.com logoDaVita Medical Insights: Launching a Podcast for Physicians, by Physicians
finance.yahoo.com - May 23 at 12:23 PM
americanbankingnews.com logoDavita Inc (DVA) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - May 22 at 12:24 PM
finance.yahoo.com logoDaVita Reports on 2016 Corporate Social Responsibility and Innovation
finance.yahoo.com - May 22 at 11:51 AM
finance.yahoo.com logoPaul Tudor Jones' Top 4 Health Care Buys
finance.yahoo.com - May 19 at 8:11 AM
finance.yahoo.com logoDaVita Clinical Research Celebrates International Clinical Trials Day
finance.yahoo.com - May 19 at 8:11 AM
finance.yahoo.com logoDr. George R. Aronoff Joins DaVita Kidney Care Physician Leadership Team
finance.yahoo.com - May 18 at 10:36 AM
americanbankingnews.com logoJavier Rodriguez Sells 1,294 Shares of Davita Inc (DVA) Stock
www.americanbankingnews.com - May 17 at 11:15 PM
finance.yahoo.com logoDaVita Supports World Hypertension Day
finance.yahoo.com - May 17 at 4:53 PM
nasdaq.com logoOversold Conditions For DaVita (DVA)
www.nasdaq.com - May 16 at 9:49 PM
nasdaq.com logoNoteworthy Tuesday Option Activity: MMM, SIG, DVA
www.nasdaq.com - May 16 at 4:48 PM
prnewswire.com logoDaVita and Bridge of Life Partner to Provide Health Screenings and Access to ...
www.prnewswire.com - May 16 at 12:31 PM
finance.yahoo.com logoDaVita and Bridge of Life Partner to Provide Health Screenings and Access to Health Care in Haiti and Nicaragua
finance.yahoo.com - May 16 at 12:31 PM
benzinga.com logoDavita Responds To John Oliver Dialysis Criticism: We Run A 'Pretty Lean Operation' - Benzinga
www.benzinga.com - May 15 at 4:10 PM
finance.yahoo.com logoJohn Oliver tackled a healthcare story last night, and it was a thing of beauty
finance.yahoo.com - May 15 at 4:10 PM
feeds.benzinga.com logoDavita Responds To John Oliver Dialysis Criticism: We Run A 'Pretty Lean Operation'
feeds.benzinga.com - May 15 at 3:22 PM
finance.yahoo.com logoJohn Oliver ripped into a CEO who proudly compared his healthcare business to Taco Bell
finance.yahoo.com - May 15 at 11:48 AM
prnewswire.com logoDaVita Helps Raise Awareness of Mental Illness During Mental Health Month - PR Newswire (press release)
www.prnewswire.com - May 12 at 8:50 PM
finance.yahoo.com logoDaVita Helps Raise Awareness of Mental Illness During Mental Health Month
finance.yahoo.com - May 12 at 3:48 PM
americanbankingnews.com logoDavita Inc (DVA) Director Sells $553,641.20 in Stock
www.americanbankingnews.com - May 11 at 10:15 PM
finance.yahoo.com logoBusiness-backed open primary elections are about to become Colorado law
finance.yahoo.com - May 10 at 5:00 PM
bizjournals.com logoDaVita buys Delafield dialysis clinic operator
www.bizjournals.com - May 9 at 4:48 PM
streetinsider.com logoDaVita (DVA) Buys Purity Dialysis
www.streetinsider.com - May 9 at 6:45 AM
bizjournals.com logoDaVita scoops up Wisconsin operator of dialysis clinics
www.bizjournals.com - May 9 at 6:45 AM
americanbankingnews.com logoWilliam L. Roper Sells 12,994 Shares of Davita Inc (DVA) Stock
www.americanbankingnews.com - May 8 at 4:30 PM
americanbankingnews.com logoDavita Inc (DVA) Forecasted to Earn FY2017 Earnings of $3.53 Per Share
www.americanbankingnews.com - May 8 at 10:22 AM
streetinsider.com logoDaVita (DVA) Buys Purity Dialysis - StreetInsider.com
www.streetinsider.com - May 8 at 9:20 AM
finance.yahoo.com logoDaVita Celebrates National Nurses Week
finance.yahoo.com - May 8 at 9:20 AM
finance.yahoo.com logoDaVita Acquires Purity Dialysis
finance.yahoo.com - May 8 at 9:20 AM
americanbankingnews.com logoWilliam Blair Research Analysts Reduce Earnings Estimates for Davita Inc (DVA)
www.americanbankingnews.com - May 5 at 1:59 PM
americanbankingnews.com logoKeyCorp Equities Analysts Boost Earnings Estimates for Davita Inc (DVA)
www.americanbankingnews.com - May 5 at 9:29 AM
streetinsider.com logoDaVita (DVA) Divests 7 Dialysis Facilities in NJ & TX to Physicians Dialysis - StreetInsider.com
www.streetinsider.com - May 4 at 10:07 PM
americanbankingnews.com logoQ1 2018 EPS Estimates for Davita Inc Cut by Analyst (DVA)
www.americanbankingnews.com - May 4 at 5:54 PM
nasdaq.com logoDaVita Breaks Below 200-Day Moving Average - Notable for DVA
www.nasdaq.com - May 4 at 4:59 PM
finance.yahoo.com logoPhysicians Dialysis Acquires Seven Dialysis Facilities in New Jersey and Texas
finance.yahoo.com - May 4 at 4:59 PM
streetinsider.com logoDaVita (DVA) Misses Q1 EPS by 3c - StreetInsider.com
www.streetinsider.com - May 4 at 9:32 AM
finance.yahoo.com logoDaVita (DVA) Earnings Miss Estimates, Revenues Beat in Q1 - Yahoo Finance
finance.yahoo.com - May 4 at 9:32 AM
finance.yahoo.com logoDaVita, Inc. breached its 50 day moving average in a Bearish Manner : DVA-US : May 4, 2017
finance.yahoo.com - May 4 at 9:32 AM
americanbankingnews.com logoDavita Inc Forecasted to Post Q2 2017 Earnings of $0.91 Per Share (DVA)
www.americanbankingnews.com - May 4 at 8:32 AM



Davita (DVA) Chart for Sunday, May, 28, 2017

This page was last updated on 5/28/2017 by MarketBeat.com Staff